Germany to share patient data to support personalised medicines

With rising complications in healthcare and diseases, personalised medicines seem to offer patients with the best chances of success. However, patients respond to treatments in different ways and so finding the optimal treatment per patient requires large volumes of patient data. Currently, Italy has been a front-runner for gene therapies due to its patient registries system, allowing healthcare providers to monitor patient’s and choose the most appropriate treatment course.

Despite being rooted in a culture where data protection is crucial, Germans are very willing to share their patient data in the interests of research even if they aren’t a cancer patient themselves.

Read the full story here.

Tagged with

Published 19. February 2018 in News Germany